-
公开(公告)号:US3984401A
公开(公告)日:1976-10-05
申请号:US422748
申请日:1973-12-07
申请人: Shinji Terao , Mitsuru Shiraishi , Toshio Miyawaki , Isao Minamida , Masayoshi Yamaoka , Yoshio Imashiro , Mitsuo Numata
发明人: Shinji Terao , Mitsuru Shiraishi , Toshio Miyawaki , Isao Minamida , Masayoshi Yamaoka , Yoshio Imashiro , Mitsuo Numata
IPC分类号: A61K31/545 , C07D501/04 , C07D501/16 , C07D501/26 , C07D501/60 , C07D513/14 , C07D515/14
CPC分类号: C07D501/04 , C07D501/26
摘要: A 3-hydroxymethylcephalosporin which is not protected at the carboxyl group can be directly oxidized with a hexavalent chromium compound to give in good yield a lactol type cephalosporin represented by the general formula: ##SPC1##Wherein R.sup.1 is hydrogen or an alkoxy group and R.sup.2 is an acylamino, or imido group. The resulting compounds are very useful and important as intermediates for preparing, e.g. 3-alkoxyiminomethyl cephalosporins.
摘要翻译: 在羧基上未被保护的3-羟甲基头孢菌素可以用六价铬化合物直接氧化,得到良好的产率,由通式表示的乳糖型头孢菌素:
-
2.
公开(公告)号:US4011214A
公开(公告)日:1977-03-08
申请号:US534787
申请日:1974-12-20
申请人: Shinji Terao , Mitsuru Shiraishi , Toshio Miyawaki , Isao Minamida , Masayoshi Yamaoka , Mitsuo Numata
发明人: Shinji Terao , Mitsuru Shiraishi , Toshio Miyawaki , Isao Minamida , Masayoshi Yamaoka , Mitsuo Numata
IPC分类号: C07D501/24 , A61K31/43 , A61K31/545 , A61K31/546 , A61P31/04 , C07D20060101 , C07D501/04 , C07D501/38 , C07D501/50 , C07D501/52 , C07D501/54 , C07D501/60
CPC分类号: C07D501/38
摘要: Novel cephalosporin compounds of the formula ##STR1## wherein R.sup.1 is an acyl group and R.sup.2 is an alkylene group which may be substituted with a lower alkoxyl group, or pharmaceutically acceptable salt thereof, have strong inhibitory actions on broad spectra of gram-positive and gram-negative bacteria and, particularly against Esherichia coli and Klebsiella pneumoniae. Thus, the compounds are useful as therapeutic agent for various bacterial infections of animals including human beings.
-
公开(公告)号:US4517361A
公开(公告)日:1985-05-14
申请号:US480791
申请日:1983-03-31
IPC分类号: C07D277/34 , C07D277/36 , C07D501/24 , C07D501/34 , C07D501/36 , C07D501/28
CPC分类号: C07D501/24 , C07D277/34 , C07D277/36
摘要: A compound of the formula: ##STR1## wherein R.sup.1 represents hydrogen or an alkyl group, X represents oxygen or sulfur or a group of formula -NR.sup.2 (where R.sup.2 is hydrogen or an alkyl group and in the case of alkyl, it may form a ring jointed with R.sup.1), and Y represents acetoxy group or a group of formula -SR.sup.3 (where R.sup.3 is a nitrogen-containing heterocyclic group), or a pharmaceutically acceptable salt thereof, is found to have a broad antimicrobial spectrum and, in particular, effective against gram-negative bacteria including Escherichia coli, Klebsiella pneumoniae, Proteus vulgaris, Proteus morganii, as well as gram positive ones. Thus, these compounds may be used for antimicrobial agents in therapeutical purposes.
摘要翻译: 下式的化合物:其中R 1表示氢或烷基,X表示氧或硫或式-NR 2基团(其中R 2是氢或烷基,在烷基的情况下可以形成 环与R 1连接),Y表示乙酰氧基或式-SR 3(其中R 3为含氮杂环基)基团或其药学上可接受的盐具有宽的抗菌谱,特别是, 对革兰氏阴性菌有效,包括大肠杆菌,肺炎克雷伯杆菌,普通变形杆菌,变形杆菌,以及革兰氏阳性菌。 因此,这些化合物可用于治疗目的的抗微生物剂。
-
公开(公告)号:US4080498A
公开(公告)日:1978-03-21
申请号:US534782
申请日:1974-12-20
IPC分类号: C07D277/34 , C07D277/36 , C07D501/24 , C07D501/34 , C07D501/36 , C07D501/60
CPC分类号: C07D501/24 , C07D277/34 , C07D277/36
摘要: A compound of the formula: ##STR1## wherein R.sup.1 represents hydrogen or an alkyl group, X represents oxygen or sulfur or a group of formula --NR.sup.2 (where R.sup.2 is hydrogen or an alkyl group and in the case of alkyl, it may form a ring jointed with R.sup.1), and Y represents acetoxy group or a group of formula --SR.sup.3 (where R.sup.3 is a nitrogen-containing heterocyclic group), or a pharmaceutically acceptable salt thereof, is found to have a broad antimicrobial spectrum and, in particular, effective against gram-negative bacteria including Escherichia coli, Klebsiella pneumoniae, Proteus vulgaris, Proteus morganii, as well as gram positive ones. Thus, these compounds may be used for antimicrobial agents in therapeutical purposes.
摘要翻译: 下式的化合物:其中R 1表示氢或烷基,X表示氧或硫或式-NR 2基团(其中R 2是氢或烷基,在烷基的情况下可以形成 环与R 1连接),Y表示乙酰氧基或式-SR 3(其中R 3为含氮杂环基)基团或其药学上可接受的盐具有宽的抗菌谱,特别是, 对革兰氏阴性菌有效,包括大肠杆菌,肺炎克雷伯杆菌,普通变形杆菌,变形杆菌,以及革兰氏阳性菌。 因此,这些化合物可用于治疗目的的抗微生物剂。
-
公开(公告)号:US4421912A
公开(公告)日:1983-12-20
申请号:US235609
申请日:1981-02-18
IPC分类号: C07D277/34 , C07D277/36 , C07D501/24 , C07D501/34 , C07D501/36
CPC分类号: C07D501/24 , C07D277/34 , C07D277/36
摘要: A compound of the formula: ##STR1## wherein R.sup.1 represents hydrogen or an alkyl group, X represents oxygen or sulfur or a group of formula --NR.sup.2 (where R.sup.2 is hydrogen or an alkyl group and in the case of alkyl, it may form a ring jointed with R.sup.1), and Y represents acetoxy group or a group of formula --SR.sup.3 (where R.sup.3 is a nitrogen-containing heterocyclic group), or a pharmaceutically acceptable salt thereof, is found to have a broad antimicrobial spectrum and, in particular, effective against gram-negative bacteria including Escherichia coli, Klebsiella pneumoniae, Proteus vulgaris, Proteus morganii, as well as gram positive ones. Thus, these compounds may be used for antimicrobial agents in therapeutical purposes.
-
公开(公告)号:US4379924A
公开(公告)日:1983-04-12
申请号:US863719
申请日:1977-12-23
IPC分类号: C07D277/34 , C07D277/36 , C07D501/36 , A61K31/545
CPC分类号: C07D501/24 , C07D277/34 , C07D277/36
摘要: A compound of the formula: ##STR1## wherein R.sup.1 represents hydrogen or an alkyl group, X represents oxygen or sulfur or a group of formula --NR.sup.2 (where R.sup.2 is hydrogen or an alkyl group and in the case of alkyl, it may form a ring jointed with R.sup.1), and Y represents acetoxy group or a group of formula --SR.sup.3 (where R.sup.3 is a nitrogen-containing heterocyclic group), or a pharmaceutically acceptable salt thereof, is found to have a broad antimicrobial spectrum and, in particular, effective against gram-negative bacteria including Escherichia coli, Klebsiella pneumoniae, Proteus vulgaris, Proteus morganii, as well as gram positive ones. Thus, these compounds may be used for antimicrobial agents in therapeutical purposes.
-
公开(公告)号:US20060106067A1
公开(公告)日:2006-05-18
申请号:US10524452
申请日:2003-08-11
申请人: Mitsuru Shiraishi , Takahito Hara , Masami Kusaka , Naoyuki Kanzaki , Satoshi Yamamoto , Toshio Miyawaki
发明人: Mitsuru Shiraishi , Takahito Hara , Masami Kusaka , Naoyuki Kanzaki , Satoshi Yamamoto , Toshio Miyawaki
IPC分类号: A61K31/454 , C07D409/02
CPC分类号: C07C255/52 , C07C35/52 , C07C217/04 , C07C255/53 , C07C255/54 , C07C255/56 , C07C2601/08 , C07C2601/10 , C07D207/06 , C07D207/08 , C07D207/10 , C07D207/12 , C07D207/14 , C07D207/16 , C07D207/22 , C07D207/24 , C07D209/46 , C07D211/22 , C07D211/28 , C07D211/34 , C07D211/42 , C07D211/46 , C07D211/60 , C07D211/62 , C07D211/74 , C07D231/08 , C07D261/04 , C07D265/02 , C07D267/10 , C07D295/073 , C07D295/112 , C07D295/155 , C07D303/46 , C07D307/79 , C07D333/54 , C07D405/04 , C07D409/04 , C07D491/10
摘要: The present invention provides a compound represented by the general formula: [wherein Ring A represents an optionally substituted 5- to 8-membered ring, Ring B represents a further optionally substituted 4- to 10-membered ring, Ring C represents a further optionally substituted benzene ring, X1 represents carbon atom, X2 represents a carbon atom, an oxygen atom, etc., W represents a nitrogen atom, etc., Y11 represents a group represented by the formula CR2R3′ (wherein R2 represents a hydrogen atom, a cyano group, a nitro group, etc., and R3′ represents a hydrogen atom, a cyano group, a nitro group, etc., respectively), Y21 represents a group represented by the formula CR4R5′ (wherein R4 represents a hydrogen atom, a cyano group, a nitro group, etc., and R5′ represents a hydrogen atom, a cyano group, a nitro group, etc., respectively), etc., and R1 represents an electron-withdrawing group, respectively. The formula represents a single bond or a double bond] or a salt thereof, which is useful as an androgen receptor modulator.
摘要翻译: 本发明提供由以下通式表示的化合物:其中环A表示任选取代的5-至8-元环,环B表示另外任选取代的4-至10-元环,环C表示另外任选取代的 苯环,X 1表示碳原子,X 2表示碳原子,氧原子等,W表示氮原子等,Y表示碳原子, 11表示由式CR 2表示的基团R 3(其中R 2表示氢原子,氰基) ,硝基等,R 3'分别表示氢原子,氰基,硝基等),Y 21表示基团 由式CR 4 S 5 H 5(其中R 4表示氢原子,氰基,硝基等)表示, 和R 5'分别表示氢原子,氰基,硝基等)等,R 1, SUP>分别表示吸电子基团。 公式<?in-line-formula description =“In-line Formulas”end =“lead”?> <?in-line-formula description =”In-line Formulas“end =”tail“ α“表示单键或双键]或其盐,其可用作雄激素受体调节剂。
-
公开(公告)号:US07649001B2
公开(公告)日:2010-01-19
申请号:US10524452
申请日:2003-08-11
申请人: Mitsuru Shiraishi , Takahito Hara , Masami Kusaka , Naoyuki Kanzaki , Satoshi Yamamoto , Toshio Miyawaki
发明人: Mitsuru Shiraishi , Takahito Hara , Masami Kusaka , Naoyuki Kanzaki , Satoshi Yamamoto , Toshio Miyawaki
IPC分类号: A61K31/454 , C07D409/02
CPC分类号: C07C255/52 , C07C35/52 , C07C217/04 , C07C255/53 , C07C255/54 , C07C255/56 , C07C2601/08 , C07C2601/10 , C07D207/06 , C07D207/08 , C07D207/10 , C07D207/12 , C07D207/14 , C07D207/16 , C07D207/22 , C07D207/24 , C07D209/46 , C07D211/22 , C07D211/28 , C07D211/34 , C07D211/42 , C07D211/46 , C07D211/60 , C07D211/62 , C07D211/74 , C07D231/08 , C07D261/04 , C07D265/02 , C07D267/10 , C07D295/073 , C07D295/112 , C07D295/155 , C07D303/46 , C07D307/79 , C07D333/54 , C07D405/04 , C07D409/04 , C07D491/10
摘要: The present invention provides a compound represented by the general formula: [wherein Ring A represents an optionally substituted 5- to 8-membered ring, Ring B represents a further optionally substituted 4- to 10-membered ring, Ring C represents a further optionally substituted benzene ring, X1 represents carbon atom, X2 represents a carbon atom, an oxygen atom, etc., W represents a nitrogen atom, etc., Y11 represents a group represented by the formula CR2R3′ (wherein R2 represents a hydrogen atom, a cyano group, a nitro group, etc., and R3′ represents a hydrogen atom, a cyano group, a nitro group, etc., respectively), Y21 represents a group represented by the formula CR4R5′ (wherein R4 represents a hydrogen atom, a cyano group, a nitro group, etc., and R5′ represents a hydrogen atom, a cyano group, a nitro group, etc., respectively), etc., and R1 represents an electron-withdrawing group, respectively. The formula represents a single bond or a double bond] or a salt thereof, which is useful as an androgen receptor modulator.
摘要翻译: 本发明提供由以下通式表示的化合物:其中环A表示任选取代的5-至8-元环,环B表示另外任选取代的4-至10-元环,环C表示另外任选取代的 苯环,X1表示碳原子,X2表示碳原子,氧原子等,W表示氮原子等,Y11表示由式CR2R3'表示的基团(其中R2表示氢原子,氰基 基,硝基等,R3'分别表示氢原子,氰基,硝基等),Y21表示由式CR4R5'表示的基团(其中R4表示氢原子, 氰基,硝基等,R5'分别表示氢原子,氰基,硝基等),R1表示吸电子基团。 公式表示单键或双键]或其盐,其可用作雄激素受体调节剂。
-
公开(公告)号:US5344928A
公开(公告)日:1994-09-06
申请号:US868100
申请日:1992-04-14
IPC分类号: C07C381/02 , C07D207/40 , C07D207/404 , C07D279/18 , C07D417/12 , C07D417/14 , G01N33/533 , C07D279/28
CPC分类号: C07D207/404 , C07C381/02 , C07D279/18 , C07D417/12 , C07D417/14 , G01N33/533 , Y10S436/811
摘要: There is disclosed a novel phenothiazine derivative of the general formula (I): ##STR1## wherein R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are the same or different and are a C.sub.1-6 alkyl group and at least one of them has as a substituent a group which can react with amino group, thiol group or carboxyl group, and X.sup.- is a counter ion of the phenazathionium. Their production and the intermediates used in the production are also disclosed. The compound (I) is a derivative of methylene blue and is applicable to photodynamic therapy of cancer or immunoassays utilizing chemiluminescence.
摘要翻译: 公开了通式(I)的新型吩噻嗪衍生物:其中R 1,R 2,R 3和R 4相同或不同,为C 1-6烷基,并且其中至少一个具有 可以与氨基,硫醇基或羧基反应的基团的取代基,X-是对硝基苯甲酸的抗衡离子。 他们的生产和生产中使用的中间体也被披露。 化合物(I)是亚甲蓝的衍生物,适用于利用化学发光的癌症或免疫测定的光动力学治疗。
-
公开(公告)号:US09108986B2
公开(公告)日:2015-08-18
申请号:US14232589
申请日:2012-07-13
IPC分类号: C07D215/00 , C07F5/00 , C07D215/04 , C07B53/00 , C07F17/02 , C07D215/06 , C07D215/18 , C07D215/20 , C07D215/22 , C07D215/227 , C07D215/14
CPC分类号: C07F5/00 , B01J31/181 , B01J31/2295 , B01J2231/643 , B01J2531/0275 , B01J2531/827 , C07B53/00 , C07D215/04 , C07D215/06 , C07D215/14 , C07D215/18 , C07D215/20 , C07D215/22 , C07D215/227 , C07F17/02
摘要: Provided are a novel chiral iridium(III) complex; and a method for producing optically active 2-substituted-1,2,3,4-tetrahydroquinolines from 2-substituted-quinolines with the use of the chiral iridium(III) complex through a more economical and easy production process. The disclosed method for producing optically active 2-substituted-1,2,3,4-tetrahydroquinolines comprises reducing a quinoline compound represented by formula [I]: in the presence of a hydrogen donor compound and an iridium (III) complex having a chiral prolinamide compound as a ligand to give an optically active 2-substituted-1,2,3,4-tetrahydroquinoline represented by formula [II]:
摘要翻译: 提供了一种新型的手性铱(III)络合物; 以及通过更经济和容易的制备方法,通过使用手性铱(III)络合物从2-取代的喹啉生产光学活性的2-取代-1,2,3,4-四氢喹啉的方法。 所公开的光学活性2-取代-1,2,3,4-四氢喹啉的制备方法包括还原由式[I]表示的喹啉化合物:在氢供体化合物和具有手性的铱(III)络合物存在下, 脯氨酰胺化合物作为配体,得到式[II]表示的光学活性2-取代-1,2,3,4-四氢喹啉:
-
-
-
-
-
-
-
-
-